They identified reprogramming of the AR cistrome between benign prostate tissues, hormone sensitive prostate cancer tissues, and CRPC tissues, identifying over 17,000 AR binding sites and over 16,000 H3K27ac sites enriched in CRPC (103). This evidence concerns the gene AR and prostate cancer.